Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariangela Salvato

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Autoimmunity Reviews|August 26, 2023
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?Mariangela Salvato, Andrea Doria
Rheumatology (Oxford, England)|February 4, 2024
Very-low-dose glucocorticoid therapy in rheumatoid arthritis: impact of b/tsDMARDs initiation timing on glucocorticoid withdrawalAlessandro Giollo, Mariangela Salvato, Francesca Frizzera, et al.
Mayo Clinic Proceedings|September 1, 2025
Long-term Outcomes Based on the Sex of the Rheumatologist in a Prospective Cohort of Rheumatoid Arthritis PatientsAlessandro Giollo, Mariangela Salvato, Francesca Frizzera, et al.
Autoimmunity Reviews|August 31, 2023
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debateMaurizio Cutolo, Yehuda Shoenfeld, Dimitrios P Bogdanos, et al.
Seminars in Arthritis and Rheumatism|December 10, 2024
Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysisMarco Binda, Augusta Ortolan, Beatrice Moccaldi, et al.
Rheumatology (Oxford, England)|September 28, 2024
Anti-pentraxin 3 antibodies and residual disease activity in rheumatoid arthritisMariangela Salvato, Francesca Frizzera, Anna Ghirardello, et al.
Arthritis Research & Therapy|December 19, 2025
Safety of JAK inhibitors versus other biologic therapies following anti-TNF failure in patients with rheumatoid arthritisLorenzo Di Luozzo, Mariangela Salvato, Francesca Frizzera, et al.
Autoimmunity Reviews|July 27, 2025
Primordial and primary prevention in rheumatological diseases: The time has comeLaura Scagnellato, Mariangela Salvato, Luca Iorio, et al.
Rheumatology (Oxford, England)|November 17, 2025
The impact of glucocorticoids on the efficacy of JAK inhibitors or non-TNF-targeted biologics in rheumatoid arthritisMariangela Salvato, Benedetta Salvatori, Francesca Frizzera, et al.
Rheumatology (Oxford, England)|October 3, 2022
Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort studyAlessandro Giollo, Margherita Zen, Maddalena Larosa, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Autoimmunity Reviews|August 26, 2023
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?Mariangela Salvato, Andrea Doria
Rheumatology (Oxford, England)|February 4, 2024
Very-low-dose glucocorticoid therapy in rheumatoid arthritis: impact of b/tsDMARDs initiation timing on glucocorticoid withdrawalAlessandro Giollo, Mariangela Salvato, Francesca Frizzera, et al.
Mayo Clinic Proceedings|September 1, 2025
Long-term Outcomes Based on the Sex of the Rheumatologist in a Prospective Cohort of Rheumatoid Arthritis PatientsAlessandro Giollo, Mariangela Salvato, Francesca Frizzera, et al.
Autoimmunity Reviews|August 31, 2023
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debateMaurizio Cutolo, Yehuda Shoenfeld, Dimitrios P Bogdanos, et al.
Seminars in Arthritis and Rheumatism|December 10, 2024
Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysisMarco Binda, Augusta Ortolan, Beatrice Moccaldi, et al.
Rheumatology (Oxford, England)|September 28, 2024
Anti-pentraxin 3 antibodies and residual disease activity in rheumatoid arthritisMariangela Salvato, Francesca Frizzera, Anna Ghirardello, et al.
Arthritis Research & Therapy|December 19, 2025
Safety of JAK inhibitors versus other biologic therapies following anti-TNF failure in patients with rheumatoid arthritisLorenzo Di Luozzo, Mariangela Salvato, Francesca Frizzera, et al.
Autoimmunity Reviews|July 27, 2025
Primordial and primary prevention in rheumatological diseases: The time has comeLaura Scagnellato, Mariangela Salvato, Luca Iorio, et al.
Rheumatology (Oxford, England)|November 17, 2025
The impact of glucocorticoids on the efficacy of JAK inhibitors or non-TNF-targeted biologics in rheumatoid arthritisMariangela Salvato, Benedetta Salvatori, Francesca Frizzera, et al.
Rheumatology (Oxford, England)|October 3, 2022
Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort studyAlessandro Giollo, Margherita Zen, Maddalena Larosa, et al.
Pageof 2